CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo
Open Access
- 17 August 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 128 (2), 337-346
- https://doi.org/10.1007/s10549-010-1085-7
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant MetastasisCancer Cell, 2009
- Modes of resistance to anti-angiogenic therapyNature Reviews Cancer, 2008
- The effect of thrombospondin-1 on breast cancer metastasisBreast Cancer Research and Treatment, 2008
- Thrombospondins: from structure to therapeuticsCellular and Molecular Life Sciences, 2008
- Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast CancerThe New England Journal of Medicine, 2007
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- Thrombospondin-1 and transforming growth factor-betal promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin systemSurgery, 1997
- Inhibition of Angiogenesis by Thrombospondin-2Biochemical and Biophysical Research Communications, 1995
- Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cellsCancer, 1995
- Tumor Angiogenesis: Therapeutic ImplicationsThe New England Journal of Medicine, 1971